Moretto R, Falcone A, Cremolini C. Duration of oxaliplatin-based adjuvant chemotherapy in patients with stage III or high-risk stage II resected colon cancer. Int J Cancer 2020 Jan 22. doi: 10.1002/ijc.32884.
PMID: 31970766